IFT20 Antibody - Western Blot Validated

About the Target

Use this antibody to investigate IFT20 in your model system. IFT20 is a microtubule-organizing element often evaluated in cell-cycle and cilia studies. Focus on trends across conditions rather than single-point snapshots.

Tracking IFT20 can clarify whether changes reflect regulation, redistribution, or altered complex assembly.

Research Context

Disruption of intraflagellar transport or basal body function can produce distinct localization signatures. Pair measurements with orthogonal readouts when interpretation is sensitive to context.

Consider these angles when interpreting target-level changes:

• co-occurrence with intraflagellar transport markers
• cell-cycle linked differences in localization
• signal enrichment at basal bodies versus cytoplasm
• changes in cilia incidence or apparent length in perturbation studies

Variant Considerations

If your primary readout depends on denatured protein presentation, this option can streamline comparison across lanes and conditions. This matters because epitope exposure and background can vary with preparation and extraction steps. If you compare conditions, keep processing steps uniform to support clean interpretation.

When interpreting IFT20, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

If your study spans multiple model systems, it can help to define a shared reference condition for IFT20 so cross-sample contrasts stay meaningful.

For challenging targets, pairing IFT20 measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

Select the denaturing-format version to keep IFT20 interpretation aligned with your workflow goals.